Simple view
Full metadata view
Authors
Statistics
Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries
Journal
Frontiers in Pharmacology
40
Author
Volume
9
Article ID
975
eISSN
1663-9812
Keywords in English
CEE countries
orphan medicinal products
reimbursement
rare diseases
biotechnology
Language
English
Journal language
English
Affiliation
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego
Scopus© citations
15
| dc.affiliation | Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego | pl |
| dc.cm.date | 2020-01-07 | |
| dc.cm.id | 89921 | |
| dc.contributor.author | Kamusheva, Maria | pl |
| dc.contributor.author | Manova, Manoela | pl |
| dc.contributor.author | Savova, Alexandra T. | pl |
| dc.contributor.author | Petrova, Guenka I. | pl |
| dc.contributor.author | Mitov, Konstantin | pl |
| dc.contributor.author | Harsányi, András | pl |
| dc.contributor.author | Kaló, Zoltán | pl |
| dc.contributor.author | Márky, Kristóf | pl |
| dc.contributor.author | Kawalec, Paweł - 130055 | pl |
| dc.contributor.author | Angelovska, Bistra | pl |
| dc.contributor.author | Lakić, Dragan | pl |
| dc.contributor.author | Tesar, Tomas | pl |
| dc.contributor.author | Draganic, Pero | pl |
| dc.contributor.author | Geitona, Mary | pl |
| dc.contributor.author | Hatzikou, Magdalini | pl |
| dc.contributor.author | Paveliu,Marian Sorin | pl |
| dc.contributor.author | Männik, Agnes | pl |
| dc.date.accessioned | 2020-01-17T10:00:00Z | |
| dc.date.available | 2020-01-17T10:00:00Z | |
| dc.date.issued | 2018 | pl |
| dc.date.openaccess | 0 | |
| dc.description.accesstime | w momencie opublikowania | |
| dc.description.points | 40 | pl |
| dc.description.version | ostateczna wersja wydawcy | |
| dc.description.volume | 9 | pl |
| dc.identifier.articleid | 975 | pl |
| dc.identifier.doi | 10.3389/fphar.2018.00795 | pl |
| dc.identifier.eissn | 1663-9812 | |
| dc.identifier.project | ROD UJ / OP | pl |
| dc.identifier.uri | https://ruj.uj.edu.pl/xmlui/handle/item/143587 | |
| dc.language | eng | pl |
| dc.language.container | eng | pl |
| dc.rights | Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa | * |
| dc.rights.licence | CC-BY | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/legalcode.pl | * |
| dc.share.type | otwarte czasopismo | |
| dc.source.integrator | false | |
| dc.subject.en | CEE countries | pl |
| dc.subject.en | orphan medicinal products | pl |
| dc.subject.en | reimbursement | pl |
| dc.subject.en | rare diseases | pl |
| dc.subject.en | biotechnology | pl |
| dc.subtype | Article | pl |
| dc.title | Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries | pl |
| dc.title.journal | Frontiers in Pharmacology | pl |
| dc.type | JournalArticle | pl |
| dspace.entity.type | Publication |
dc.affiliationpl
Wydział Nauk o Zdrowiu : Instytut Zdrowia Publicznego dc.cm.date
2020-01-07 dc.cm.id
89921 dc.contributor.authorpl
Kamusheva, Maria dc.contributor.authorpl
Manova, Manoela dc.contributor.authorpl
Savova, Alexandra T. dc.contributor.authorpl
Petrova, Guenka I. dc.contributor.authorpl
Mitov, Konstantin dc.contributor.authorpl
Harsányi, András dc.contributor.authorpl
Kaló, Zoltán dc.contributor.authorpl
Márky, Kristóf dc.contributor.authorpl
Kawalec, Paweł - 130055 dc.contributor.authorpl
Angelovska, Bistra dc.contributor.authorpl
Lakić, Dragan dc.contributor.authorpl
Tesar, Tomas dc.contributor.authorpl
Draganic, Pero dc.contributor.authorpl
Geitona, Mary dc.contributor.authorpl
Hatzikou, Magdalini dc.contributor.authorpl
Paveliu,Marian Sorin dc.contributor.authorpl
Männik, Agnes dc.date.accessioned
2020-01-17T10:00:00Z dc.date.available
2020-01-17T10:00:00Z dc.date.issuedpl
2018 dc.date.openaccess
0 dc.description.accesstime
w momencie opublikowania dc.description.pointspl
40 dc.description.version
ostateczna wersja wydawcy dc.description.volumepl
9 dc.identifier.articleidpl
975 dc.identifier.doipl
10.3389/fphar.2018.00795 dc.identifier.eissn
1663-9812 dc.identifier.projectpl
ROD UJ / OP dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/143587 dc.languagepl
eng dc.language.containerpl
eng dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa dc.rights.licence
CC-BY dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl dc.share.type
otwarte czasopismo dc.source.integrator
false dc.subject.enpl
CEE countries dc.subject.enpl
orphan medicinal products dc.subject.enpl
reimbursement dc.subject.enpl
rare diseases dc.subject.enpl
biotechnology dc.subtypepl
Article dc.titlepl
Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries dc.title.journalpl
Frontiers in Pharmacology dc.typepl
JournalArticle dspace.entity.type
Publication Affiliations
Wydział Nauk o Zdrowiu
Kawalec, Paweł
No affiliation
Kamusheva, Maria
Manova, Manoela
Savova, Alexandra T.
Petrova, Guenka I.
Mitov, Konstantin
Harsányi, András
Kaló, Zoltán
Márky, Kristóf
Angelovska, Bistra
Lakić, Dragan
Tesar, Tomas
Draganic, Pero
Geitona, Mary
Hatzikou, Magdalini
Paveliu,Marian Sorin
Männik, Agnes
* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.
Views
9
Views per month
Views per city
Ashburn
4
Wroclaw
2
Des Moines
1
Dublin
1
Szczecin
1
Downloads
kawalec_et-al_comparative_analysis_of_legislative_requirements_2018.pdf
36
kawalec_et-al_comparative_analysis_of_legislative_requirements_2018.odt
14
Open Access
Loading...